The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis

Sandra Torres, Maximilian J Brol, Fernando Magdaleno, Robert Schierwagen, Frank E. Uschner, Sabine Klein, Cristina Ortiz, Olaf Tyc, Nadine Bachtler, James Stunden, Damien Bertheloot, Ana Kitanovic, Brian Sanchez, Jacob Schrum, William R. Roush, Luigi Franchi, Kate Byth, Eicke Latz, Jonel Trebicka

Open source

DOI: 10.3389/fmolb.2021.715765
Published: 2021-08-13
Container: Frontiers in Molecular Biosciences
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmolb.2021.715765,
  title = {The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis},
  author = {Sandra Torres and Maximilian J Brol and Fernando Magdaleno and Robert Schierwagen and Frank E. Uschner and Sabine Klein and Cristina Ortiz and Olaf Tyc and Nadine Bachtler and James Stunden and Damien Bertheloot and Ana Kitanovic and Brian Sanchez and Jacob Schrum and William R. Roush and Luigi Franchi and Kate Byth and Eicke Latz and Jonel Trebicka},
  year = {2021},
  journal = {Frontiers in Molecular Biosciences},
  doi = {10.3389/fmolb.2021.715765},
  url = {https://doi.org/10.3389/fmolb.2021.715765}
}

RIS

TY  - JOUR
TI  - The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
AU  - Sandra Torres
AU  - Maximilian J Brol
AU  - Fernando Magdaleno
AU  - Robert Schierwagen
AU  - Frank E. Uschner
AU  - Sabine Klein
AU  - Cristina Ortiz
AU  - Olaf Tyc
AU  - Nadine Bachtler
AU  - James Stunden
AU  - Damien Bertheloot
AU  - Ana Kitanovic
AU  - Brian Sanchez
AU  - Jacob Schrum
AU  - William R. Roush
AU  - Luigi Franchi
AU  - Kate Byth
AU  - Eicke Latz
AU  - Jonel Trebicka
PY  - 2021
JO  - Frontiers in Molecular Biosciences
DO  - 10.3389/fmolb.2021.715765
UR  - https://doi.org/10.3389/fmolb.2021.715765
ER  -

APA

Torres, S., Brol, M. J., Magdaleno, F., Schierwagen, R., Uschner, F. E., Klein, S., Ortiz, C., Tyc, O., Bachtler, N., Stunden, J., Bertheloot, D., Kitanovic, A., Sanchez, B., Schrum, J., Roush, W. R., Franchi, L., Byth, K., Latz, E., & Trebicka, J. (2021). The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2021.715765

Source records

crossref · retrieved 2026-09-26T22:57:41.877Z